Status:
ACTIVE_NOT_RECRUITING
Elevating Voices, Addressing Depression, Toxic Stress and Equity in Group Prenatal Care
Lead Sponsor:
Washington University School of Medicine
Conditions:
Pregnancy Related
Perinatal Depression
Eligibility:
FEMALE
13+ years
Phase:
NA
Brief Summary
This study will provide high-quality, representative data on the capacity of Elevating Voices, Addressing Depression, Toxic Stress and Equity in Group Prenatal Care (EleVATE GC) to reduce perinatal de...
Eligibility Criteria
Inclusion
- English or Spanish speaking
- ≤18 weeks' gestation
- Established prenatal care at EleVATE site
- High-risk for postpartum depression by ≥1 risk factor (personal/family history, baseline EPDS≥10, low-income, 13-19 years old, single, history of physical/sexual abuse, unplanned/undesired pregnancy, history of pregnancy loss)
- Ability to attend group prenatal visits at specified days/times
- Willingness to be randomized
- Ability to give informed consent
- Any patient that has received prenatal care in a group setting previously
Exclusion
- Multiple gestation
- Major fetal anomaly
- Serious medical co-morbidity/psychiatric illness necessitating more care than can be safely provided in group setting
- Serious medical co-morbidity necessitating more care than can be safely provided in group setting
Key Trial Info
Start Date :
May 21 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2026
Estimated Enrollment :
416 Patients enrolled
Trial Details
Trial ID
NCT04838210
Start Date
May 21 2021
End Date
June 30 2026
Last Update
January 5 2026
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Missouri-Kansas City/Truman Health Centers-Kansas City
Kansas City, Missouri, United States, 64108
2
Affinia Healthcare
St Louis, Missouri, United States, 63104
3
Family Care Health Centers
St Louis, Missouri, United States, 63111
4
CareSTL Health
St Louis, Missouri, United States, 63112